Navigation Links
Global IVF Devices Market to Grow at a CAGR of 10.46% by 2021 - Analysis By Product & End User - Research and Markets
Date:4/13/2017

DUBLIN, Apr. 13, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global IVF Devices Market 2017-2021" report to their offering.

The global IVF devices market to grow at a CAGR of 10.46% during the period 2017-2021.

The report, Global Thoracic Surgery Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend in market is growing number of fertility clinics. The rise in the number of fertility clinics has led to an increased accessibility for IVF procedures. An estimated 3,000 fertility clinics operate worldwide, with about 650 clinics in India. The rise in the number of fertility clinics allows couples to choose clinics based on their convenience. Smaller countries in terms of the area such as Ukraine and the Czech Republic have 16 and 30 fertility clinics, respectively. There are over 650 fertility clinics in India helping in assisting sterile couples. The rise in the number of fertility clinics in China and India are beneficial in assisting the couples. Due to the rise in awareness, many couples facing infertility problems seek medical intervention. This has led to a growing need for IVF and registered ART clinics in the region.

According to the report, one driver in market is cross-border medical tourism. Medical tourism also helps patients access medical care at affordable costs. Couples facing infertility problems can choose the best clinics for their treatment. For instance, the IVF treatment cost in the US is $12,000-$14,000, whereas in other countries such as India and Sri Lanka it is $2,000-$6,000. Hence, couples who cannot afford IVF treatment in the US can move to other countries for the treatment. Many clinics offer infertility treatment in EMEA. The medical tourism for infertility treatment in EMEA is high, due to the use of advanced technologies, the availability of skilled professionals, and low treatment cost compared with the other developed regions. This is expected to propel the growth of the market during the forecast period.

Key vendors

  • Cook Medical
  • CooperSurgical
  • Thermo Fisher Scientific
  • Vitrolife

Other prominent vendors

  • CellCura
  • EMD Serono
  • Esco Micro
  • Hamilton Thorne
  • Others

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by product

PART 07: Market segmentation by end-user

PART 08: Geographical segmentation

PART 09: Decision framework

PART 10: Drivers and challenges

PART 11: Market trends

PART 12: Vendor landscape

PART 13: Key vendor analysis

PART 14: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/sb828v/global_ivf

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-ivf-devices-market-to-grow-at-a-cagr-of-1046-by-2021---analysis-by-product--end-user---research-and-markets-300439514.html


'/>"/>
SOURCE Research and Markets
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Information Online Market Research Portal Provides Complimentary Sample Service for Customers to Preview Reports by Global Industry Analysts
2. Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New York
3. The Rockley Group and Content Rules Ink Deal to Extend Global Reach
4. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
5. Amgen To Present At The UBS Global Life Sciences Conference
6. HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast
7. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City
8. PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems
9. Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
10. TRACE Releases 2012 Global Enforcement Report
11. Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2017)... , Sept. 5, 2017  Just 18 months ... Insight is pleased to announce the appointment of three ... Tammy Wynne , Dominic Jones-Phillips and ... industry. Tammy ... team of market access writers. She has over ten ...
(Date:9/1/2017)... Ind. , Sept. 1, 2017  Explorers Like Us ... capture America,s greatest aural experiences — and deliver these experiences ... experience to help people feel and heal better. ... While nothing beats a ... and refresh your mind, Life Environments™ is the next best ...
(Date:8/29/2017)... Va. , Aug. 29, 2017 ivWatch, LLC, the ... peripheral IV infiltrations, announced it has been awarded an Innovative Technology ... company in the country. ... continuous monitoring device to aid in the early detection of peripheral ... The Innovative ...
Breaking Medicine Technology:
(Date:9/20/2017)... , ... September 20, 2017 , ... ... Maintain® methodology and industry-leading compliance software, The Guard®, has helped another long-time client ... (OCR) HIPAA audit and properly satisfy the law. , Thanks to the help ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... digital and social campaign, “Humans With Vaginas.” The goal is to ignite conversation ... of non-toxic personal care products. The brand has declared September “Humans with Vaginas” ...
(Date:9/20/2017)... ... 20, 2017 , ... Medicare doesn’t have the authority to ... for their prescription drugs, according to a new comparison of drug plans by ... behalf, there’s no consistency in drug pricing among drug plans,” states TSCL’s Medicare ...
(Date:9/20/2017)... ... ... “The Trials I Face to Receive God’s Grace”: a mesmerizing take on ... to better one’s life through God. “The Trials I Face to Receive God’s Grace” ... places, found a love for writing. Green feels that expressing his feelings through prayer ...
(Date:9/20/2017)... ... ... Houston, Texas, investment firm CORDA Investment Management, LLC, believes in giving back. ... work and rolled up their sleeves to help with relief efforts. The team picked ... process of rebuilding. , CORDA founder Bonner C. Barnes notes that investment management firms ...
Breaking Medicine News(10 mins):